Cargando…

Molecular epidemiology of hepatitis B virus infection in Norway

BACKGROUND: Hepatitis B virus (HBV) infection remains a serious global health challenge. The widespread distribution of HBV is highlighted by multiple HBV genotypes associated with different geographical origin and transmission patterns, as well as, clinical outcomes. Investigating population HBV ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettersson, John H.-O., Myking, Solveig, Elshaug, Hilde, Bygdås, Kirsten Irene Ege, Stene-Johansen, Kathrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407267/
https://www.ncbi.nlm.nih.gov/pubmed/30845915
http://dx.doi.org/10.1186/s12879-019-3868-8
_version_ 1783401513871212544
author Pettersson, John H.-O.
Myking, Solveig
Elshaug, Hilde
Bygdås, Kirsten Irene Ege
Stene-Johansen, Kathrine
author_facet Pettersson, John H.-O.
Myking, Solveig
Elshaug, Hilde
Bygdås, Kirsten Irene Ege
Stene-Johansen, Kathrine
author_sort Pettersson, John H.-O.
collection PubMed
description BACKGROUND: Hepatitis B virus (HBV) infection remains a serious global health challenge. The widespread distribution of HBV is highlighted by multiple HBV genotypes associated with different geographical origin and transmission patterns, as well as, clinical outcomes. Investigating population HBV genotype composition and origin is therefore highly warranted. METHODS: In this molecular epidemiological study we analysed 1157 HBV S-gene sequences collected from patients in Norway, primarily in the period 2004–2011, and linked them to epidemiological data from the Norwegian surveillance system for communicable diseases. RESULTS: Of the patients with reported country of infection (n = 909), 10% (n = 93) were infected in Norway, but the majority (n = 816; 90%) stated that they became infected outside of Norway. Of the patients infected outside of Norway, most became infected in Southeast and East Asia (n = 465; 51%) and Central, West, and North Africa (n = 254; 28%). The distribution of HBV genotypes in Norway is dominated by genotype D (32%) followed by genotype A (22%), B and C (18 and 18%, respectively), and E (7%). Genotype B, C and E were phylogenetically categorized by a majority of sequences originating from distinct geographical regions, either Asia or Africa, whereas genotype A and D originated from multiple geographic regions. However, within genotype A and D, our molecular epidemiology analysis indicated a geographical clustering of sequences depending on their geographical origin. CONCLUSIONS: The majority of HBV patients in Norway became infected outside of Norway and were represented by most common genotypes. Patients stated to have been infected in Norway were found primarily within genotype A and D, and were phylogenetically characterized by both small local clusters and interspersed sequences that clustered with non-Norwegian sequences, indicating that a proportion of the patients assumed to have been infected in Norway likely became infected outside of Norway although assumed the contrary. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-3868-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6407267
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64072672019-03-21 Molecular epidemiology of hepatitis B virus infection in Norway Pettersson, John H.-O. Myking, Solveig Elshaug, Hilde Bygdås, Kirsten Irene Ege Stene-Johansen, Kathrine BMC Infect Dis Research Article BACKGROUND: Hepatitis B virus (HBV) infection remains a serious global health challenge. The widespread distribution of HBV is highlighted by multiple HBV genotypes associated with different geographical origin and transmission patterns, as well as, clinical outcomes. Investigating population HBV genotype composition and origin is therefore highly warranted. METHODS: In this molecular epidemiological study we analysed 1157 HBV S-gene sequences collected from patients in Norway, primarily in the period 2004–2011, and linked them to epidemiological data from the Norwegian surveillance system for communicable diseases. RESULTS: Of the patients with reported country of infection (n = 909), 10% (n = 93) were infected in Norway, but the majority (n = 816; 90%) stated that they became infected outside of Norway. Of the patients infected outside of Norway, most became infected in Southeast and East Asia (n = 465; 51%) and Central, West, and North Africa (n = 254; 28%). The distribution of HBV genotypes in Norway is dominated by genotype D (32%) followed by genotype A (22%), B and C (18 and 18%, respectively), and E (7%). Genotype B, C and E were phylogenetically categorized by a majority of sequences originating from distinct geographical regions, either Asia or Africa, whereas genotype A and D originated from multiple geographic regions. However, within genotype A and D, our molecular epidemiology analysis indicated a geographical clustering of sequences depending on their geographical origin. CONCLUSIONS: The majority of HBV patients in Norway became infected outside of Norway and were represented by most common genotypes. Patients stated to have been infected in Norway were found primarily within genotype A and D, and were phylogenetically characterized by both small local clusters and interspersed sequences that clustered with non-Norwegian sequences, indicating that a proportion of the patients assumed to have been infected in Norway likely became infected outside of Norway although assumed the contrary. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-3868-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-07 /pmc/articles/PMC6407267/ /pubmed/30845915 http://dx.doi.org/10.1186/s12879-019-3868-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pettersson, John H.-O.
Myking, Solveig
Elshaug, Hilde
Bygdås, Kirsten Irene Ege
Stene-Johansen, Kathrine
Molecular epidemiology of hepatitis B virus infection in Norway
title Molecular epidemiology of hepatitis B virus infection in Norway
title_full Molecular epidemiology of hepatitis B virus infection in Norway
title_fullStr Molecular epidemiology of hepatitis B virus infection in Norway
title_full_unstemmed Molecular epidemiology of hepatitis B virus infection in Norway
title_short Molecular epidemiology of hepatitis B virus infection in Norway
title_sort molecular epidemiology of hepatitis b virus infection in norway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407267/
https://www.ncbi.nlm.nih.gov/pubmed/30845915
http://dx.doi.org/10.1186/s12879-019-3868-8
work_keys_str_mv AT petterssonjohnho molecularepidemiologyofhepatitisbvirusinfectioninnorway
AT mykingsolveig molecularepidemiologyofhepatitisbvirusinfectioninnorway
AT elshaughilde molecularepidemiologyofhepatitisbvirusinfectioninnorway
AT bygdaskirstenireneege molecularepidemiologyofhepatitisbvirusinfectioninnorway
AT stenejohansenkathrine molecularepidemiologyofhepatitisbvirusinfectioninnorway